Informing pandemic response in the face of uncertainty.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
03 Jul 2023
03 Jul 2023
Historique:
pubmed:
18
7
2023
medline:
18
7
2023
entrez:
18
7
2023
Statut:
epublish
Résumé
Our ability to forecast epidemics more than a few weeks into the future is constrained by the complexity of disease systems, our limited ability to measure the current state of an epidemic, and uncertainties in how human action will affect transmission. Realistic longer-term projections (spanning more than a few weeks) may, however, be possible under defined scenarios that specify the future state of critical epidemic drivers, with the additional benefit that such scenarios can be used to anticipate the comparative effect of control measures. Since December 2020, the U.S. COVID-19 Scenario Modeling Hub (SMH) has convened multiple modeling teams to make 6-month ahead projections of the number of SARS-CoV-2 cases, hospitalizations and deaths. The SMH released nearly 1.8 million national and state-level projections between February 2021 and November 2022. SMH performance varied widely as a function of both scenario validity and model calibration. Scenario assumptions were periodically invalidated by the arrival of unanticipated SARS-CoV-2 variants, but SMH still provided projections on average 22 weeks before changes in assumptions (such as virus transmissibility) invalidated scenarios and their corresponding projections. During these periods, before emergence of a novel variant, a linear opinion pool ensemble of contributed models was consistently more reliable than any single model, and projection interval coverage was near target levels for the most plausible scenarios (e.g., 79% coverage for 95% projection interval). SMH projections were used operationally to guide planning and policy at different stages of the pandemic, illustrating the value of the hub approach for long-term scenario projections.
Identifiants
pubmed: 37461674
doi: 10.1101/2023.06.28.23291998
pmc: PMC10350156
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : ACL HHS
ID : U01IP001137
Pays : United States
Organisme : NIGMS NIH HHS
ID : U24 GM132013
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM140564
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002489
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM109718
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP001136
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP001137
Pays : United States
Organisme : CDC HHS
ID : NU38OT000297
Pays : United States
Organisme : ACL HHS
ID : U01IP001136
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI151176
Pays : United States
Commentaires et corrections
Type : UpdateIn